Hemogenyx secures clearance for pediatric enrolment in leukemia trial
(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment. Read More
| Price | 1,020.00p on 29-10-2025 at 19:05:07 |
|---|---|
| Change | 40.00p 4.08% |
| Buy | 1,045.00p |
| Sell | 1,015.00p |
| Last Trade: | Sell 183.00 at 1,020.00p |
| Day's Volume: | 50,371 |
| Last Close: | 1,020.00p |
| Open: | 1,085.00p |
| ISIN: | GB00BQVXM815 |
| Day's Range | 1,015.00p - 1,120.00p |
| 52wk Range: | 0.876p - 1,790.00p |
| Market Capitalisation: | £54.68m |
| VWAP: | 1,078.49353p |
| Shares in Issue: | 5.36m |
Sector: Medicine and Biotech
Hemogenyx Pharmaceuticals (HEMO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 183 | 1,020.00p | Uncrossing Trade |
16:35:28 - 29-Oct-25 |
| Unknown* | 2 | 1,015.00p | OTC Trade |
16:22:55 - 29-Oct-25 |
| Sell* | 10 | 1,015.00p | SI Trade |
16:22:55 - 29-Oct-25 |
| Buy* | 47 | 1,045.00p | SI Trade |
16:22:55 - 29-Oct-25 |
| Sell* | 3 | 1,015.00p | Automatic Execution |
16:22:55 - 29-Oct-25 |
| Sell* | 147 | 1,024.00p | Ordinary |
16:21:09 - 29-Oct-25 |
| Buy* | 500 | 1,044.40p | Ordinary |
16:20:46 - 29-Oct-25 |
| Buy* | 500 | 1,043.20p | Ordinary |
16:06:55 - 29-Oct-25 |
| Buy* | 500 | 1,043.17p | Ordinary |
16:05:41 - 29-Oct-25 |
| Buy* | 22 | 1,047.90p | Ordinary |
15:51:31 - 29-Oct-25 |
Hemogenyx Pharmaceuticals (HEMO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 29th Oct 2025 7:00 am | RNS | Clinical Trial Update and Grant of Share Awards |
| 6th Oct 2025 7:00 am | RNS | Clearance to Initiate Pediatric Enrolment |
| 30th Sep 2025 7:00 am | RNS | Half-year Report |
| 30th Sep 2025 7:00 am | RNS | Total Voting Rights |
| 23rd Sep 2025 7:00 am | RNS | Hemogenyx Signs Letter of Intent |
| 18th Sep 2025 1:16 pm | RNS | Holding(s) in Company |
| 17th Sep 2025 7:00 am | RNS | Third Patient Safety |
| 11th Sep 2025 7:00 am | RNS-R | Invitation to Participate at DCNY Summit |
| 8th Sep 2025 7:00 am | RNS | Manufacturing Partnership with Made Scientific |
| 5th Sep 2025 7:00 am | RNS | Exercise of Warrants and Issue of Equity |